Fast Pace Mississippi, PLLC
Fast Pace Mississippi, PLLC was paid $30.46M by Medicaid between Jan 2018 and Dec 2024, across 72 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
RIPLEY, MS 38663
Next to other Clinic/Center providers in Mississippi
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43,146 | $388K | |
| 2019 | 125,920 | $3.40M | |
| 2020 | 97,599 | $3.35M | |
| 2021 | 190,751 | $8.21M | |
| 2022 | 343,650 | $7.77M | |
| 2023 | 212,900 | $4.40M | |
| 2024incomplete | 124,616 | $2.95M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 210,654 | 162,908 | $10.82M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 19% | 95,789 | 68,314 | $5.73M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 85,353 | 68,347 | $3.14M |
| 87428 | 9.3% | 70,576 | 57,064 | $2.83M | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.3% | 217,200 | 100,735 | $1.92M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.5% | 41,412 | 30,880 | $1.69M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.3% | 78,122 | 59,371 | $1.61M |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.7% | 111,828 | 84,414 | $815K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.6% | 42,302 | 33,766 | $796K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 37,530 | 27,442 | $232K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 3,157 | 2,600 | $231K |
| 99205 | Prolong outpt/office vis | <1% | 1,744 | 1,454 | $180K |
60 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,941 | $140K |
| 87807 | <1% | 17,483 | $98K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,806 | $44K |
| 96127 | <1% | 18,326 | $40K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,880 | $34K |
| 81003 | <1% | 20,629 | $18K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 535 | $16K |
| 81025 | <1% | 5,435 | $15K | |
| 99051 | <1% | 3,054 | $10K | |
| 73610 | <1% | 657 | $8K | |
| 74018 | <1% | 403 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,340 | $7K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 12,835 | $7K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 2,963 | $6K |
| 73130 | <1% | 476 | $5K | |
| 73630 | <1% | 451 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,119 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 15,662 | $3K |
| 73562 | <1% | 312 | $3K | |
| 73110 | <1% | 213 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,928 | $2K |
| S9083 | Global fee urgent care centers | <1% | 1,110 | $2K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 33 | $1K |
| 73140 | <1% | 147 | $1K | |
| 93000 | <1% | 395 | $931.17 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 64 | $929.59 |
| 82962 | <1% | 800 | $751.71 | |
| 86308 | <1% | 230 | $548.86 | |
| 69209 | <1% | 200 | $509.60 | |
| 29540 | <1% | 88 | $489.06 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 142 | $414.13 |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 214 | $272.00 |
| 87400 | <1% | 91 | $267.30 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 30 | $220.01 |
| 99401 | <1% | 38 | $198.15 | |
| 73090 | <1% | 35 | $160.62 | |
| 73030 | <1% | 19 | $147.73 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 28 | $117.00 |
| 90688 | <1% | 15 | $96.60 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 17 | $28.60 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 63 | $13.53 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 522 | $11.45 |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 1,000 | $8.85 |
| 96161 | <1% | 15 | $3.22 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 258 | $0.39 |
| 99499 | 0% | 835 | $0.00 | |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | 0% | 150 | $0.00 |
| 3725F | 0% | 8,401 | $0.00 | |
| S0077 | Injection, clindamycin phosphate, 300 mg | 0% | 29 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 61 | $0.00 |
| 80061 | Lipid panel | 0% | 48 | $0.00 |
| 3351F | 0% | 5,432 | $0.00 | |
| 3353F | 0% | 950 | $0.00 | |
| 3354F | 0% | 75 | $0.00 | |
| 3008F | 0% | 2,775 | $0.00 | |
| 3352F | 0% | 965 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 101 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 56 | $0.00 |
| 3080F | 0% | 13 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Fast Pace Mississippi, PLLC | Kosciusko, MS | $6.88M |
| FC Indiana, LLC | Bedford, IN | $1000K |
| Fast Pace Kentucky, PLLC | Madisonville, KY | $805K |
| Fast Pace Medical Clinic PLLC | Florence, AL | $794K |
| Fast Pace Kentucky, PLLC | Franklin, KY | $447K |
| Fast Pace Kentucky, PLLC | Brendenburg, KY | $388K |
| Fast Pace Kentucky, PLLC | Corbin, KY | $339K |
| Fast Pace Medical Clinic PLLC | Lincoln, AL | $176K |
| Fast Pace Medical Clinic PLLC | Sylacauga, AL | $154K |
| Fast Pace Kentucky, PLLC | Mount Washington, KY | $134K |
| Fast Pace Medical Clinic PLLC | Enterprise, AL | $80K |
| Fast Pace Medical Clinic PLLC | Jackson, AL | $46K |
| Fast Pace Medical Clinic PLLC | Centerville, AL | $40K |
| Fast Pace Kentucky PLLC | Maysville, KY | $24K |
| Fast Pace Medical Clinic PLLC | Union City, TN | $3K |
| Fast Pace Kentucky PLLC | Paris, KY | $287.73 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.